
News|Slideshows|March 4, 2025
SLIDESHOW: 2025 Pre-AAD Meetings
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
2
Tapinarof Cream Shows Consistent Response Across Pediatric AD Age Groups
3
Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas
4
Masterclass Insights: Optimizing Care for Ulcerated Hemangiomas and Café-au-Lait Macules
5











